Does ECULIZUMAB Cause Poor venous access? 555 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 555 reports of Poor venous access have been filed in association with ECULIZUMAB (SOLIRIS). This represents 1.3% of all adverse event reports for ECULIZUMAB.
555
Reports of Poor venous access with ECULIZUMAB
1.3%
of all ECULIZUMAB reports
10
Deaths
130
Hospitalizations
How Dangerous Is Poor venous access From ECULIZUMAB?
Of the 555 reports, 10 (1.8%) resulted in death, 130 (23.4%) required hospitalization, and 6 (1.1%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 555 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
IDURSULFASE (175)
Which ECULIZUMAB Alternatives Have Lower Poor venous access Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB